Results 131 to 140 of about 1,672,515 (266)

Diagnostic Documentation and Tumour Marker Availability Across Clinical Pathways in Real-World Gastric Cancer. [PDF]

open access: yesDiagnostics (Basel)
Vieru AM   +6 more
europepmc   +1 more source

Clinical Pathway Management of Tonsillectomy

open access: yesPractica oto-rhino-laryngologica. Suppl., 2015
Ida, Yutaro   +3 more
openaire   +1 more source

Tumor B‐cell infiltration in platinum‐treated advanced muscle‐invasive urothelial carcinoma

open access: yesMolecular Oncology, EarlyView.
Bladder tumors with higher pretreatment memory B‐cell infiltration were linked to longer survival after cisplatin chemotherapy, but not carboplatin. These tumors also showed more organized immune structures (tertiary lymphoid structures) and a shared pro‐inflammatory B‐cell‐rich community, suggesting that memory B cells may help identify patients most ...
Konrad Stawiski   +10 more
wiley   +1 more source

Multi-center disease-specific management system: toward standardized and harmonized clinical pathways in integrated care networks. [PDF]

open access: yesFront Public Health
Liu X   +9 more
europepmc   +1 more source

Management of Residual Risk in Chronic Coronary Syndromes. Clinical Pathways for a Quality-Based Secondary Prevention. [PDF]

open access: yesJ Clin Med, 2023
Giubilato S   +22 more
europepmc   +1 more source

Liquid biopsy‐based diagnostic evaluation of hypermethylated CpG sites for ovarian cancer diagnosis

open access: yesMolecular Oncology, EarlyView.
This schematic outlines the workflow from biomarker identification to duplex MethyLight assay validation for epithelial ovarian cancer diagnosis using cfDNA‐based liquid biopsy. Initial screening of hypermethylated CpG candidates (cg02957270, cg10061138 cg00480298, COL2A1) was performed in tissue using ARMS‐PCR, COBRA, qPCR and image analysis. Selected
Deepa Bisht   +3 more
wiley   +1 more source

Successful Implementation of Workflow-Embedded Clinical Pathways During the COVID 19 Pandemic. [PDF]

open access: yesQual Manag Health Care, 2023
Wendel SK   +3 more
europepmc   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy